Center Star Asset Management, LLC Biogen Inc. Transaction History

Center Star Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$193.77 - $244.14 $572,396 - $721,189	-2,954 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$223.92 - $287.77 $661,459 - $850,072	2,954 New	2,954 $709,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $91,824 - $121,605	-355 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$268.85 - $341.04 $95,441 - $121,069	355 New	355 $112,000
Q4 2018 Jan 16, 2019	SELL	$278.5 - $352.75 $83,828 - $106,177	-301 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$293.51 - $383.83 $1.77 Million - $2.31 Million	-6,030 Reduced 95.25%	301 $107,000
Q2 2018 Jul 09, 2018	BUY	$257.52 - $306.91 $1.6 Million - $1.91 Million	6,231 Added 6231.0%	6,331 $1.83 Million
Q1 2018 May 01, 2018	SELL	$260.13 - $367.91 $51,765 - $73,214	-199 Reduced 66.56%	100 $27,000
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $91,984 - $103,029	299	299 $96,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.